Acebutolol: Clinical Trials

7 trials of Acebutolol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated. 3 Phase 4, 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3
Not applicable1Completed 1
Phase 21Completed 1
Phase 31Terminated 1

Follow Acebutolol: new trials by email Literature Review of Acebutolol trials Research Report on Acebutolol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Beta-blockers on Physical Function in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012023-09-08
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012024-04-09
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID
CompletedUniversity of Utah222132020-01-192021-04-28
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
Acebutolol, Propanolol - Hemangioma
Phase 3TerminatedUniversity Hospital, Montpellier552012-11-012016-06-01
An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers
Acebutolol, Placebo - Healthy
Phase 4CompletedIn-Jin Jang, MD, PhD162012-01-012012-06-20
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
Rate Control, Ablation Therapy, Rate control - Atrial Fibrillation, Arrhythmia
Not applicableCompletedMayo Clinic602006-09-012013-01-04
Treatment of Mild Hypertension Study (TOMHS)
diet, sodium-restricted, diet, reducing, exercise - Cardiovascular Diseases, Heart Diseases
Phase 2CompletedUniversity of Minnesota1985-08-012016-02-25

Conditions studied

Heart Diseases (3)  ·  Heart Failure (2)  ·  Heart Failure, Diastolic (2)  ·  Hypertension (2)  ·  Arrhythmias, Cardiac (1)  ·  Atrial Fibrillation (1)  ·  Cardiovascular Diseases (1)  ·  Hemangioma (1)  ·  Vascular Diseases (1)

Sponsors

Weill Medical College of Cornell University (2)  ·  In-Jin Jang, MD, PhD (1)  ·  Mayo Clinic (1)  ·  University Hospital, Montpellier (1)  ·  University of Minnesota (1)  ·  University of Utah (1)

Countries

United States (4)  ·  France (1)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Parag Goyal, MD (2)  ·  Adam P Bress, PharmD, MS (1)  ·  Douglas L. Packer, M.D. (1)  ·  Kyoichi Ohashi, MD, PhD (1)  ·  Richard Grimm (1)

Results publications

PMID 33891615

NIH funding

K76AG064428 (1), R01HL034767 (1)